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A R T I C L E S
Although maternal mortality rates in developing countries 
have declined in recent years, they remain unacceptably 
high.1 Achieving Millennium Development Goal 5—the 
reduction of maternal mortality by three-quarters between 
1990 and 2015—remains a challenge. In Bangladesh, the 
maternal mortality ratio (MMR) declined by 66% from 
1990 to 2010, to an estimated 194 maternal deaths per 
100,000 live births.2 Although this level is high compared 
with that in developed countries, the decline is remarkable 
considering Bangladesh’s relatively unfavorable socioeco-
nomic conditions, poorly managed health infrastructure 
and low rates of institutional deliveries.1–3 The reduction in 
maternal mortality may be due to fertility decline, to chang-
es in health care–seeking behavior3 and to the availability 
of menstrual regulation (MR), a form of uterine evacuation 
that is thought to be a relatively safe method of terminat-
ing pregnancies (or suspected pregnancies). Studies sug-
gest that MR and abortion have been widespread in Ban-
gladesh,4,5 and that the incidence of the former has been 
increasing.6,7 In this study, we used longitudinal data from 
Matlab to examine the case-fatality rates associated with 
MR,* abortion and live birth. We also assessed whether the 
case-fatality rates of MR and abortion differ, and whether 
they have declined recently, as maternal mortality has. 
Pregnancy termination is legal in Bangladesh when 
practiced to save a woman’s life and, under the guise of 
MR, in the early stages of pregnancy. MR is permitted to 
bring on delayed menses within 10 weeks of a woman’s 
last menstrual period; it is done using manual or electric 
vacuum aspiration before pregnancy is clinically con-
firmed. Although we do not know of any data on how of-
ten the women who undergo MR are pregnant, we (and 
others) strongly suspect that most such women presume, 
probably correctly, that they are pregnant. MR is available 
from trained female providers—family welfare visitors at 
public-sector facilities in rural areas, and paramedics at 
nongovernmental organizations and private health centers 
in urban and rural areas. In addition, male and female phy-
sicians are trained in MR and in some cases provide the 
service. Physicians are permitted by law to perform MR up 
to 10 weeks after a woman’s last menstrual period, while 
family welfare visitors and paramedics may do so up to 
eight weeks after the last menstrual period.4 A husband’s 
consent is not legally required prior to the procedure, but 
many providers at public-sector facilities ask for it. MR is 
supposed to be free of charge from public-sector providers, 
but for various reasons clients typically pay a considerable 
amount of money, even in the public sector, for medica-
tions, laboratory tests and other out-of-pocket costs. Pro-
viders are required to keep records of MRs, which may 
raise clients’ concerns about confidentiality.
CONTEXT: In Bangladesh, both menstrual regulation (MR), which is thought to be a relatively safe method, and abor-
tion, which in this setting is often performed using unsafe methods, are used to terminate pregnancies (known or sus-
pected). However, little is known about changes over time in the use of these methods or their relative mortality risks.
METHODS: Data from the Demographic Surveillance System in Matlab, Bangladesh, on 110,152 pregnancy 
outcomes between 1989 and 2008 were used to assess changes in mortality risks associated with MR (and a small 
number of dilation and curettage procedures), abortion and live birth. Tabulation and logistic regression analyses 
were used to compare outcomes in two areas of Matlab—the comparison area, which receives standard govern-
ment health and family planning services, and the Maternal and Child Health–Family Planning (MCH-FP) area, 
which receives enhanced health and family planning services.
RESULTS: In Matlab as a whole, the proportion of pregnancies ending in MR increased from 1.9% in 1989–1999 to 
4.2% in 2000–2008, while the proportion ending in abortion decreased from 1.6% to 1.1%. The odds of mortality 
from MR were 4.1 times those from live birth in 1989–1999, but were no longer elevated in 2000–2008. The odds 
of mortality from abortion were 12.0 and 4.9 times those of live birth in 1989–1999 and 2000–2008, respectively. 
Reduction in mortality risk was greater in the MCH-FP area than the comparison area (90% vs. 75%).
CONCLUSION: MR is no longer associated with higher mortality risk than live birth in Bangladesh, but abortion is.
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maternal mortality attributable to abortion was very low—
5% in 1998–2001 and 1% in 2008–2011.2,3 In Matlab, 
surveillance data on abortion-related maternal mortality, 
which are likely to be more reliable than survey data on 
these issues, also show a decline—from 89 abortion-related 
deaths per 100,000 pregnancies in 1976–1985 and 72 per 
100,000 in 1986–1995 to 31 per 100,000 in 1996–2005—
but the proportions of maternal deaths attributable to 
abortion (20% in 1976–1995, 13% in 1996–2005) are 
considerably higher than those estimated from survey 
data.14 The discrepancy is probably due to the difficulty of 
identifying abortion cases in surveys, especially for women 
who die early in pregnancy. Family members tend not to 
report information on abortion in surveys, and the likeli-
hood of their disclosing abortion cases is probably lower 
for women who have died.
Study Area
Matlab, a rural subdistrict of Bangladesh, is well known for 
its Demographic Surveillance System (DSS), as well for the 
Maternal Child Health–Family Planning (MCH-FP) proj-
ect, which operates in half of the DSS area to provide in-
tensive, high-quality reproductive health, family planning, 
and maternal and child health services.19–21 The other 
half, known as the comparison area, is typical of much of 
Bangladesh in contraceptive use,22 fertility and childhood 
mortality,23 and maternal mortality.2 The MCH-FP area has 
lower rates of fertility,24 pregnancy termination9 and ma-
ternal mortality,12,23 provides greater coverage of antenatal 
care and offers better access to basic and emergency obstet-
ric care13,24 than the comparison area does.
Most women in Matlab deliver at home with the help of 
a traditional birth attendant, although institutional deliver-
ies, which were rare as recently as the early 1990s, have 
increased sharply in the MCH-FP area in recent years.14 
Both areas of Matlab have access to Chandpur government 
district hospital and to some private clinics that provide 
emergency and intensive-care services, including caesar-
ean delivery and blood transfusion. However, about half of 
the villages in both areas are relatively remote, and travel-
ing to Chandpur is difficult.
The MCH-FP project—a series of carefully designed 
reproductive health interventions that may directly and 
indirectly affect maternal health and mortality—was imple-
mented in Matlab in 1977. The project provided MR ser-
vices from 1978 to 1983, but not since then. Between 1978 
and 2001, female community health workers provided in-
jectable contraceptives, the pill, condoms and family plan-
ning counseling during household visits every two weeks 
(1978–1995) or monthly (1996–2001). Tetanus immuni-
Abortion remains a very sensitive topic in Bangladesh; 
many of the restrictions on MR, particularly its availability 
only before pregnancy is clinically confirmed, are meant to 
reinforce the perception that the procedure is something 
other than abortion. MR is not considered abortion by 
most women, who sometimes call the procedure “wash.” 
Dilation and curettage (D&C) is another procedure for 
pregnancy termination available from nurses or physicians 
at public and private health facilities; however, as our data 
show, its incidence is very low in our study area.
Terminating a pregnancy in a nonmedical setting or 
after pregnancy is clinically confirmed is prohibited in 
Bangladesh, except to save a woman’s life. Nevertheless, 
research suggests that clandestine and unsafe pregnancy 
terminations have been common.4,8 An abortion can be 
obtained from traditional practitioners, usually older wom-
en who perform the procedure by inserting herbal roots or 
other solid objects into the uterus. In rural areas (such as 
the one studied here) and urban slums, traditional practi-
tioners typically are more available than formally trained 
providers are. Although clandestine abortions are cheaper 
than MR, they are less safe and are a leading cause of ma-
ternal mortality and short- and long-term maternal health 
complications.
While MR is technically not regarded as pregnancy ter-
mination in Bangladesh, most studies in the reproductive 
health literature treat it as such. For example, articles on 
abortion,6–10 maternal morbidity11 and maternal mortal-
ity2,3,12–15 included MR when they referred to abortion. Be-
cause we compare mortality risks between MR and abor-
tion, as well as to be consistent with the literature, we treat 
MR as a method of pregnancy termination, and use the 
term “pregnancy termination” or “termination” to describe 
both abortion and MR (and D&C).
Maternal Mortality in Bangladesh
National data on maternal mortality in Bangladesh have 
been scarce, although some regional data from cross-
sectional surveys and high-quality longitudinal surveil-
lance have been available. During the 1980s, the maternal 
mortality ratio was estimated to be between 550 and 623 
deaths per 100,000 live births in three geographically dis-
persed districts.16–18 In Matlab, where high-quality longitu-
dinal data are available, the maternal mortality ratio was 
estimated as 443, 313 and 170 per 100,000 in the 1980s, 
1990s and early 2000s, respectively.13 Two large national 
maternal mortality surveys yielded estimates of 322 per 
100,000 in 1998–2001 and 194 per 100,000 in 2008–
2011.2,3 These findings suggest that maternal mortality has 
declined remarkably since the 1980s and that the mater-
nal mortality ratio has fallen below 200 per 100,000 live 
births.* They further indicate that Bangladesh is on track 
to meet Millennium Development Goal 5; the decline in 
maternal mortality is consistent with the country’s dra-
matic reductions in fertility and childhood mortality and 
with its rapid social development.
The two national surveys found that the proportion of 
*Global models estimate a higher maternal mortality ratio for Bangla-
desh—about 340 per 100,000 in 2008 (sources: reference 1 and Hogan 
MC et al., Maternal mortality for 181 countries, 1980–2008: a systematic 
analysis of progress towards Millennium Development Goal 5, Lancet, 
2010, 375(9726):1609–1623). However, these models may not fit the Ban-
gladesh situation, primarily because the country has experienced a rapid 
demographic transition and improvements in public health. The practice 
of MR also may contribute to the maternal mortality ratio’s being lower 
in Bangladesh than is predicted by these models.
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options and to seek care.14 Moreover, the pace of health 
care improvement has been greater in the MCH-FP area. 
Therefore, our first hypothesis is that relative to the 
comparison area, the MCH-FP area has had lower rates of 
pregnancy termination (overall and for MR and abortion 
separately); a higher proportion of terminations done by 
MR, rather than by abortion; lower case fatality for each 
type of pregnancy termination; and a greater reduction 
over time in case fatality (overall and for MR and abortion 
separately).
Each pregnancy puts a woman’s life and health at risk. In 
Bangladesh, maternal mortality is lowest for women who 
have live births and highest for women with stillbirths; 
mortality rates among women who have miscarriages or 
terminate their pregnancies fall in between.12 However, the 
mortality risks associated with MR and abortion may differ 
considerably. Worldwide, the estimated fatality rate associ-
ated with unsafe abortion was about 220 per 100,000 pro-
cedures in 2008—around 350 times that of legal abortion in 
the United States.27 Moreover, the mortality risk associated 
with pregnancy terminations performed by trained practi-
tioners in hygienic institutional settings should be lower 
than that associated with a live birth, because a full-term 
pregnancy ending in childbirth may pose greater health 
risks than an early-term pregnancy terminated under safe 
conditions. In the United States, the mortality rate among 
women who had legal abortions was less than one per 
100,000 in the 1980s and 1990s,28,29 compared with 12 
maternal deaths per 100,000 live births.1 In Bangladesh, 
however, MR is done in settings (health facilities or provid-
ers’ homes) that, especially in rural areas, may not be as 
safe as sometimes presumed. In 1996, an estimated 25% 
of women hospitalized for complications of pregnancy ter-
mination had undergone MR.5 Moreover, although more 
than 75% of pregnancy terminations were performed by 
MR, terminations accounted for 48% of obstetric compli-
cations in Jessore, Bangladesh, in 2008,11 suggesting that 
MR is associated with high levels of complications. For this 
reason, the mortality advantage of MR over live birth may 
not be as high in Matlab as in developed countries, and 
may not exist at all.
However, MR may be safer than abortion. Singh et al. 
estimated that for every 1,000 Bangladeshi women aged 
15–44, about 6.5 were treated for complications of abor-
tion and 2.2 were treated for complications of MR in 2010.4 
Thus, our second hypothesis is that the maternal mortality 
risk associated with MR will be lower than that for abor-
tion. 
As noted, maternal mortality has declined in recent 
years in Bangladesh, purportedly because of increases in 
access to health programs, in women’s education levels, 
in health awareness (and associated behavior) and in 
economic conditions, all of which allow women to pro-
cure health services, including in life-threatening circum- 
stances.3 For example, among women with maternal com-
plications, the proportion seeking treatment from provid-
ers increased from 53% in 1998–2001 to 68% in 2008–
zation was introduced in 1979, and coverage has been uni-
versal since 1990. In 1982, a basic safe-motherhood inter-
vention, which included antenatal screening performed by 
female community health workers using a simple screen-
ing tool, was initiated. Additional safe-motherhood inter-
ventions were introduced beginning in 1987, when four 
health centers were established in the area; four trained 
midwives, on call 24 hours a day, were posted in two of the 
four health centers to attend at-home deliveries. Midwives 
encouraged pregnant women with complications to seek 
care from the Matlab Heath Center, where emergency care 
(but not caesarean section or blood transfusion) was avail-
able; women with serious complications were transported 
to the district hospital in Chandpur. In 1990, midwives 
were posted in the other two health centers to provide the 
above-mentioned services. Since 1983, pregnant women in 
the MCH-FP area have received from community health 
workers information about antenatal care, as well as a card 
depicting common pregnancy complications; women are 
referred to midwives for counseling and for antenatal and 
delivery services. From 1996 to 2002, 58% of pregnant 
women received at least one antenatal check-up from the 
health centers; of those who did, 90% had a check-up dur-
ing their third trimester.24 Between 1996 and 2001, the 
project replaced home-based maternity care by midwives 
with facility-based obstetric and delivery care at the four 
health centers; since 2001, health and family planning ser-
vices have also been provided at these centers, and post-
abortion care is available as well. The MCH-FP project has 
made systematic efforts to increase institutional deliveries 
at the four health centers.13,14,25,26
As mentioned, the comparison area is served by the 
standard government program, and residents do not have 
access to the range of maternal health services available 
in the MCH-FP area. For example, in 2005, only 14% of 
deliveries in the comparison area occurred in facilities, 
compared with 53% of those in the MCH-FP area.14 Access 
to MR and abortion is similar in the two areas; the former 
is provided by government providers and the latter by un-
skilled providers. However, because women in the MCH-
FP area have greater access to reproductive health informa-
tion and counseling than do their peers in the comparison 
area, they are more likely to opt for safer termination meth-
ods, such as MR, than are women in the comparison area.
Hypotheses
We tested several hypotheses about the incidence of MR 
and abortion, their case-fatality rates, changes in these 
measures over time, and the relationship between the 
MCH-FP program and termination incidence and case fa-
tality. A companion article investigates correlates of the two 
types of termination.6 As mentioned, women in the MCH-
FP area have greater access to quality reproductive health 
information, counseling, family planning services and 
postabortion care services than those in the comparison 
area; they are less likely to have unintended pregnancies 
and are more likely to be aware of appropriate health care 
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other 1,722 terminations during the study period (33%)—
what we call abortions—were done using other methods, 
which the DSS records in layman’s terms. The two main 
methods of abortion recorded in the survey were internal 
manipulation of the female genitalia (821 pregnancies) 
and drug application (594 pregnancies); other reported 
methods were manipulation of the abdomen (80), injec-
tions (72) and drug ingestion (47). Abortion method was 
not recorded for 108 cases. Our classification of MR and 
abortion may not be exactly comparable to the terminolo-
gies used in other studies.30
The DSS records causes of death. The completeness of 
these records is very high, but maternal death may be un-
derreported because of misclassification. The DSS defines 
a maternal death as “the death of a woman during preg-
nancy or within 42 days of pregnancy outcome from any 
cause related to or aggravated by the pregnancy or its man-
agement, but not from accidental or incidental causes.”31 
Investigators collected further information to improve the 
identification of maternal deaths that occurred between 
1976 and 2005 and their causes.23,26,32 As part of this ef-
fort, trained female interviewers collected data from rela-
tives of all deceased women aged 15–49 under investiga-
tion, medical assistants conducted verbal autopsies with 
relatives of the deceased, and a team of physicians re-
viewed all of the information related to the cause of death. 
The investigators used an extended definition of maternal 
death—a death within 90 days of a pregnancy outcome33—
and this is the definition we used in this study (including 
for deaths after 2005). We repeated our analyses for mater-
nal deaths within 42 days; the main findings did not differ 
from those reported here.
We examined all pregnancies that occurred in Matlab 
in 1989–2008 (excluding 2001). We excluded from the 
analysis 1,073 pregnancies that resulted in multiple births 
(twins or triplets), because women with such outcomes 
may have different mortality risks. We also excluded 75 
cases in which the woman died during pregnancy before 
having an outcome and 15 accidental deaths that occurred 
during pregnancy. We used the resulting sample, consist-
ing of 121,464 pregnancy outcomes, to calculate the inci-
dence of MR and abortion among women with singleton 
pregnancies.
The sample for our mortality analyses excluded 3,426 
pregnancies that ended in stillbirth and 7,886 that ended 
in spontaneous miscarriage, because we examined the 
mortality associated with these outcomes in a previous 
study.12 The sample for the mortality analyses thus consist-
ed of 110,152 singleton pregnancies—104,941 resulting in 
live births, 3,489 ending in MR and 1,722 ending in abor-
tion. Using DSS identification numbers to match death re-
cords with records on pregnancy outcomes, we identified 
2010, and the proportion seeking treatment at facilities 
nearly doubled, from 15% to 29%.3
Moreover, advances in infrastructure, technology and 
medicine have facilitated access to care among women 
with complications of pregnancy termination. Road net-
works have expanded; access to transportation has im-
proved; use of cell phones has become widespread, allow-
ing women to obtain information and locate and mobilize 
emergency services in a timely fashion; and the availability 
of antibiotics has improved markedly through provision 
by less-skilled health-care providers. Several trends in care-
seeking, such as women using safer termination methods 
at earlier stages of pregnancy (when the risk of complica-
tions is relatively low), also may be contributing to declines 
in case-fatality rates from pregnancy termination. 
Thus, we examined the following hypotheses: The mor-
tality risks associated with MR and abortion have each 
declined; the decline in mortality risk from pregnancy ter-
mination is due both to reductions in the case-fatality rates 
and to changes in the relative shares of MR and abortion; 
pregnancies are being terminated at earlier stages than in 
the past; and women are using safer abortion methods 
than they did previously.
DATA AND METHODS
The Matlab DSS contains longitudinal records of pregnan-
cy outcomes and deaths of household members. During 
their regular visits to each household—every two weeks in 
1966–1999, monthly in 2000–2006 and bimonthly since 
2007—female community health workers record women’s 
pregnancy status and any pregnancy outcomes that oc-
curred since the previous visit. Pregnancy outcomes are 
classified as live births, stillbirths, spontaneous miscar-
riages or induced miscarriages. The last category encom-
passes what we refer to as pregnancy terminations. 
The coverage of pregnancy outcomes in the DSS ap-
pears to be quite complete; because female community 
health workers make regular household visits and are well 
known to and trusted by the community, women report 
the outcomes of almost all pregnancies, including those 
that are terminated. However, some underreporting is pos-
sible because of the stigma associated with abortion.8,19 
Moreover, pregnancies that women recognize after a com-
munity health worker visits and terminate before the next 
visit would not be recorded as terminations unless report-
ed as such by the women; these pregnancies would be of 
quite short duration.*
Since 1989, the DSS has collected information on the 
method of pregnancy termination reported by respon-
dents, although for unknown reasons this distinction was 
not made in 2001. Excluding that year, a total of 5,211 
pregnancy terminations were recorded by the DSS in 
1989–2008. Of these, 3,383 (65%) were by MR and 106 
(2%) by D&C; in this study, we refer to pregnancy termi-
nations done using either method as MRs, because D&C 
(which is provided by trained nurses or physicians) should 
be a relatively safe method of pregnancy termination. The 
*Since the intervals between interviews have become longer over time, 
such underreporting, if it exists, would lead to an overestimate of the 
extent of decrease in the incidence of termination or an underestimate 
of the extent of increase. As we show below, we found an increase in 
the incidence of termination; hence, the extent of that increase may be 
somewhat larger than reported here.
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method and in method-specific case fatality to the over-
all case-fatality rate. In particular, we applied the method- 
specific case-fatality rates for 2000–2008 to the distribu-
tion of termination methods in 1989–1999 and compared 
the resulting rate to the actual maternal mortality rates in 
both periods. We did this for Matlab as a whole and for 
each subarea.
In addition, to shed more light on trends in maternal 
mortality, we looked at changes in pregnancy duration 
prior to MR or abortion to see if termination services were 
sought at an earlier stage of pregnancy than in the past. 
We used data on the duration of pregnancy at the time of 
termination for cases in which the date of a woman’s last 
menstrual period was reported.‡ We also looked at the dis-
tributions of methods for abortions reported in the DSS to 
see if there had been a change in the proportion of women 
using each abortion method. We did this for each time pe-
riod for Matlab as a whole; however, sample sizes were too 
small to permit us to look at differences between the two 
subareas. Similarly, our sample was not large enough for 
us to examine differences in case-fatality rates according to 
pregnancy duration or abortion method.
RESULTS
For Matlab as a whole, the proportion of pregnancies that 
were terminated (by either MR or abortion) increased from 
3.5% in 1989–1999 to 5.4% in 2000–2008 (Table 1). In-
creases occurred in both subareas—from 2.3% to 3.9% in 
the MCH-FP area and from 4.6% to 6.8% in the compari-
son area. The incidence of MR increased as well, and to 
a greater extent than did overall termination: from 1.9% 
to 4.2% for Matlab as a whole, from 1.3% to 3.1% in the 
MCH-FP area and from 2.4% to 5.3% in the comparison 
area. The incidence of abortion, however, declined from 
1.6% to 1.1% for Matlab as a whole, from 1.0% to 0.8% in 
the MCH-FP area and from 2.1% to 1.5% in the compari-
son area. In both time periods, the incidence of MR and of 
abortion was lower in the MCH-FP area than in the com-
parison area, as we had hypothesized (odds ratios, 0.5–
0.6). For Matlab as a whole, the share of terminations done 
by MR increased from 55% in 1989–1999 to 79% in 2000–
2008. This share also increased in both subareas. However, 
153 maternal deaths among these 110,152 pregnancies.*
We compared the mortality risks associated with MR 
and abortion with that associated with live birth, sepa-
rately for the time periods 1989–1999 and 2000–2008† 
and separately for the two areas of Matlab. We calculated 
the maternal mortality risk, or case-fatality rate, for each 
outcome by dividing the number of deaths associated 
with that outcome by the number of such outcomes, and 
present these as risks per 100,000 outcomes. We note that 
some of the cell sizes are quite small for assessing case-
fatality rates; although the level of maternal mortality in 
Bangladesh is high compared with that in other countries, 
maternal death is still a relatively rare event. Appendix 
Table 1 (page 116) shows case-fatality rates and the num-
bers of deaths and cases for the subgroups we consider. 
For example, in the MCH-FP area, there were 329 abor-
tions and seven deaths in 1989–1999, and 197 abortions 
and one death in 2000–2008.
To compare risks by pregnancy outcome, time period 
and area, we calculated odds ratios. To assess whether 
the mortality risks associated with MR or abortion differ 
from that associated with live birth when demographic 
and socioeconomic characteristics are held constant, we 
estimated adjusted odds ratios using logistic regressions 
that adjusted for factors linked to maternal mortality in 
previous studies: maternal age, pregnancy order, interpreg-
nancy interval, previous child deaths, previous pregnancy 
losses, maternal education, household space (a proxy for 
household wealth), religion and calendar year.
We also performed a simulation to understand the rela-
tive contributions of changes in the type of termination 
*During the study period, there were 58,096 pregnancy outcomes in the 
comparison area and 52,056 in the MCH-FP area, yielding annual means 
of 3,058 and 2,740. On average, about 30,000 women aged 15–49 lived 
in each area.
†Our companion article6 reports trends by year in MR and abortion.
‡In the MCH-FP area, the date of a woman’s last menstrual period was 
reported in about 90% of cases. However, in the comparison area, the 
date of last menstrual period was not available before 2001 and thus is 
available for only 46% of cases in 1989–2008. We calculated the dura-
tion of pregnancy by subtracting the date of conception (estimated as 
the date of the last menstrual period plus two weeks) from the date of 
termination, and provide data for both time periods for the MCH-FP area 
and for the later period for the comparison area.
TABLE 1. Selected indicators of pregnancy outcomes, menstrual regulation† and induced abortion, by time period and area, Matlab, Bangladesh, 
1989–2008
 Indicator 1989–1999 2000–2008‡
All MCH-FP Comparison Odds All MCH-FP Comparison Odds
area  area ratio area area ratio
No. of pregnancy outcomes§ 71,100 32,575 38,525 na 50,364 24,778 25,586 na 
Pregnancy terminations per 100 pregnancy outcomes 3.54 2.33 4.57 0.51*** 5.35 3.85 6.79 0.57***
Menstrual regulations† per 100 pregnancy outcomes 1.93 1.32 2.44 0.54*** 4.21 3.06 5.32 0.57***
Abortions per 100 pregnancy outcomes 1.62 1.01 2.13 0.47*** 1.14 0.80 1.47 0.54***
% of terminations done by menstrual regulation 54.5 57.1 53.4 1.07 78.7 79.5 78.4  1.01
***p<.001. †Includes pregnancy terminations performed by dilation and curettage, which accounted for 2% of terminations in this category. ‡Data not available for 2001. §Includes live births, 
stillbirths, miscarriages, menstrual regulations and abortions; excludes multifetal pregnancies. Notes: Odds ratios are for the MCH-FP area relative to the comparison area. The changes be-
tween 1989–1999 and 2000–2008 in the incidence of pregnancy termination, menstrual regulation and abortion are statistically significant at p<.05 for the total sample and for the subareas 
separately. The changes between 1989–1999 and 2000–2008 in the proportion of all terminations that were by menstrual regulation are statistically significant at p<.001 for the total sample 
and for the subareas separately. Sum of menstrual regulations and abortions may not equal pregnancy terminations because of rounding. na=not applicable. 
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no difference was apparent between areas in either time pe-
riod, so our hypothesis that the share of terminations that 
were done by MR would be greater in the MCH-FP area 
than in the comparison area was not supported.
In Matlab as a whole, the maternal mortality risk (or 
case-fatality rate) for abortion was larger than that for MR 
in both time periods (Figure 1; data and results of sig-
nificance testing are shown in Appendix Table 1). In the 
MCH-FP area, the difference was statistically significant for 
the earlier time period (2,128 vs. 233 per 100,000 proce-
dures, respectively); although a similar pattern was evident 
in 2000–2008 (508 vs. 0 per 100,000), we could not test 
this difference statistically because of the zero value for 
MR. The differences between the case-fatality rates for the 
two methods were not statistically significant in the com-
parison area in either time period. Thus, our hypothesis 
that the maternal mortality risk associated with MR would 
be lower than that for abortion was supported for Matlab 
as a whole, but not for the comparison area.
Figure 1 and Appendix Table 1 also show moderate 
declines in the case-fatality rate for live births—by 14% in 
Matlab as a whole, 8% in the comparison area and 18% in 
the MCH-FP area—although none of these changes were 
statistically significant.
Much greater declines in case fatality were apparent for 
pregnancies that were terminated. In Matlab as a whole, 
the fatality rate from pregnancy termination fell from 953 
per 100,000 in 1989–1999 to 186 per 100,000 in 2000–
2008, an 81% decline (Appendix Table 1). The decline was 
greater in the MCH-FP area (90%) than in the comparison 
area (75%). Rates also decreased for each of the two cate-
gories of termination methods. For Matlab as a whole, case 
fatality from abortion fell by 65%, from 1,480 per 100,000 
to 524 per 100,000. The decline in case fatality from MR 
was even greater—82% (from 511 to 94 per 100,000).
The decrease in maternal mortality associated with 
abortion was 56% in the comparison area and 76% in the 
MCH-FP area. The difference between areas was not statisti-
cally significant, contrary to our hypothesis. The difference 
between areas was more pronounced for MR: Case fatality 
declined by 77% in the comparison area, but by even more 
in the MCH-FP area, where no deaths occurred among the 
758 women who had an MR in 2000–2008. However, the 
lack of deaths precluded a statistical comparison. 
TABLE 2. Unadjusted odds ratios from logistic regression analyses comparing risk of maternal mortality in selected pairs of 
pregnancy outcomes, by time period and area
Comparison 1989–1999 2000–2008†
All Comparison MCH-FP All Comparison MCH-FP
area area area area
All pregnancy terminations relative to live birth 7.70*** 7.45*** 8.41*** 1.71 2.04 1.01
Menstrual regulation‡ relative to live birth 4.11*** 5.21*** 1.84 0.87 1.30 Undefined§
Abortion relative to live birth 12.02*** 10.02*** 17.14*** 4.85** 4.74* 4.90
Menstrual regulation‡ relative to induced abortion 0.34* 0.52 0.11* 0.18* 0.27 Undefined§
*p<.05. **p<.01. ***p<.001. †Data not available for 2001. ‡Includes pregnancy terminations performed by dilation and curettage, which accounted for 2% of 
terminations in this category. §Odds ratio could not be calculated because no deaths occurred in the menstrual regulation group.
FIGURE 1. Maternal mortality risk by type of pregnancy 
outcome, according to time period, Matlab, Bangladesh, 
1989–2008
Note: Maternal mortality risk is measured as deaths per 100,000 out-
comes. †Data not available for 2001. ‡Includes pregnancy terminations 
performed by dilation and curettage, which accounted for 2% of termi-
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We also estimated adjusted odds ratios for all of the cells 
in Table 2. These analyses adjusted for maternal age, gra-
vidity, pregnancy interval, previous child deaths, previous 
pregnancy losses, maternal education, household space, 
religion and calendar year. Results (not shown) were simi-
lar to those in Table 2. For 1989–1999, nearly all of the 
associations that had been statistically significant in the 
unadjusted analyses remained so in the adjusted analyses 
(p<.05), although the odds ratios were generally smaller; 
the exception was the comparison between MR and live 
births in the total sample, which was no longer significant. 
In contrast, none of the adjusted odds ratios for the later 
time period were statistically significant, meaning that in 
both areas the excess risk of dying from abortion or MR 
was no longer apparent.
To understand the relative contributions of two trends—
change in the distribution of termination methods, and 
changes in method-specific case-fatality rates—to the over-
all case-fatality rate, we calculated what the rate would 
have been in 2000–2008 if the proportions of termina-
tions done by MR and abortion had remained unchanged 
from 1989–1999 but the method-specific case-fatality rate 
had been that of 2000–2008. The results indicate that 
for Matlab as a whole, the case fatality from all termina-
tions would have been 290 per 100,000 instead of the 
observed 186 per 100,000 (Table 3), meaning that the 
decline would have been 70% rather than the 81% that 
actually occurred. This suggests that most of the decline in 
the case-fatality rate (86%, or 70/81) is attributable to the 
decrease in method-specific mortality risks. The propor-
tion of the decline due to changes in method-specific case- 
fatality rates was similar in the two subareas—85% for the 
comparison area and 88% for the MCH-FP area. Given that 
considerable changes in the proportion of terminations 
done by each method occurred during the study period, 
the proportion of the decline that was due to these changes 
was surprisingly small—15% for the comparison area and 
12% for the MCH-FP area. Hence, while our results sup-
port the hypothesis that the decline in the mortality risk 
from pregnancy termination was due both to reductions in 
the case-fatality rates for MR and abortion and to changes 
in the relative usage of these two methods, the former ac-
counts for much more of the decline than the latter does.
Our final analyses examined whether improvements 
in care-seeking behavior may have contributed to the de-
In 1989–1999, the case-fatality rate from abortion was 
1,220 per 100,000 in the comparison area and 2,128 per 
100,000 in the MCH-FP area; the difference is not statisti-
cally significant, a finding contrary to our expectation that 
the rate would be lower in the MCH-FP area. The 2000–
2008 case-fatality rates associated with abortion were simi-
lar in the comparison and MCH-FP areas (532 and 508 per 
100,000, respectively). The case-fatality rates from MR in 
the comparison and MCH-FP areas were 638 and 233 per 
100,000, respectively, in 1989–1999, and 147 and 0 per 
100,000 in 2000–2008; the former difference was not sig-
nificant and the latter, again, could not be analyzed statis-
tically. Nonetheless, these results support our hypothesis 
that mortality risks associated with MR and abortion have 
each declined. The hypothesis that the MCH-FP area had 
lower case-fatality rates than the comparison area was not 
supported, however.
Table 2 (page 113) shows these data in another way—
as odds ratios comparing the mortality risks associated 
with MR, abortion or both relative to the risk associated 
with live births. A marked change in fatality risk occurred 
between 1989–1999 and 2000–2008, as values were sub-
stantially higher in the former period than in the latter. 
For the earlier period, all of the odds ratios for these com-
parisons are very large and highly statistically significant, 
with the exception of the comparison between MR and live 
birth in the MCH-FP area. For example, in the comparison 
area, the odds of death among women who had had an 
MR were 5.2 times those among women who had a live 
birth, and the odds among women who had had an abor-
tion were 10.0 times those among women who had had 
a live birth. Similarly, in this earlier time period, women 
in the MCH-FP area who had had an abortion had 17.1 
times the odds of dying relative to those who had had live 
births. In 2000–2008, overall termination and MR were 
no longer associated with elevated mortality risks in either 
subarea or in Matlab as a whole. However, mortality was 
higher for abortion than for live birth in the comparison 
area (odds ratio, 4.7) and in Matlab overall (4.9); the odds 
ratio for the MCH-FP area was similar in magnitude (4.9) 
but not statistically significant, most likely because of the 
small number of abortions in the area in that time period. 
Mortality risk from MR was significantly lower than that 
from abortion in both time periods (0.3 in 1989–1999 and 
0.2 in 2000–2008) in Matlab as a whole.
TABLE 3. Observed case-fatality rates in 1989–2008, and simulated rates in 2000–2008 under scenario in which proportions 
of termination methods were those of 1989–1999, by area   
Area Observed Simulated % of decline % of decline
attributable to attributable
Case-fatality rate for all  % decline Case-fatality rate % decline changes in to change in
pregnancy terminations for all pregnancy method-specific method usage
terminations, case-fatality rates
1989–1999 2000–2008 2000–2008
All 953 186 81 290 70 86 14
Comparison 909 230 75 326 64 85 15
MCH-FP 1,055 105 90 220 79 88 12
Notes: All rates are per 100,000 cases. Data not available for 2001.
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later were similar in the two areas in 2000–2008.
There also appears to have been an improvement in the 
methods of abortion women use. In 1989–1999, 64% of 
women who obtained an abortion had their termination 
through “internal manipulation of female genitalia”; this 
proportion fell to 16% in 2000–2008 (Table 5). Converse-
ly, the use of drugs (by insertion, ingestion or injection) 
increased from 28% to 68%. These changes support our 
final hypothesis, that safer ways of termination have been 
used in recent years. Because internal manipulation of the 
female genitalia may be more likely than other approaches 
to lead to infection, women who have an abortion are prob-
ably less likely to become infected than they were in the 
past. We should note, however, that we do not know what 
drugs women used to terminate pregnancy. One may be 
misoprostol, which has been available over the counter in 
pharmacies in Bangladesh in recent years.
DISCUSSION
We analyzed high-quality longitudinal data on more than 
110,000 pregnancies that ended in a live birth, MR or abor-
tion over a period of 20 years in Matlab, Bangladesh. In 
1989–1999, roughly half of terminations (55%) were by 
MR (or, in a small proportion of cases, D&C), and the rest 
were by presumably less-safe methods (illegal abortion). 
During the next decade (2000–2008), the proportion of 
terminations performed using safe methods increased 
to 79%. This figure is much higher than that recently re-
ported by Singh and colleagues, who analyzed data from a 
2010 national survey and found that the incidence of MR 
and that of abortion were almost equal.4 However, that 
study was national and used an indirect estimation tech-
nique, which may account for the difference in findings.
The incidence of MR and abortion were significantly 
clines in mortality from pregnancy termination. First, we 
assessed whether women sought to terminate pregnancies 
earlier in pregnancy than previously. In the MCH-FP area, 
the proportion of MRs and abortions that were performed 
at later gestational ages declined (Table 4). For example, 
in 1989–1999, 28% of MRs were performed at 12 weeks 
or later, compared with 17% in 2000–2008. (MR is not 
legally permitted after 10 weeks of pregnancy, but, as our 
data show, such procedures do occur.*) Similarly, 46% of 
abortions were performed at 12 weeks or later in 1989–
1999, compared with 35% of those in 2000–2008. These 
findings support the hypothesis that in recent years preg-
nancies were terminated earlier than in the past.
The data also show that, in both time periods and in 
both regions, MRs were performed earlier during preg-
nancy than abortions were, which may help explain why 
case-fatality rates were lower for the former than for the 
latter. For example, in the earlier time period, MRs were 
performed, on average, about a week earlier than abortions 
were (7.8 vs. 8.7 weeks). Moreover, a comparison of the 
two Matlab areas shows that in 2000–2008 (the only pe-
riod for which we have data on both areas), 17% of MRs 
were done at 12 weeks or later in the MCH-FP area, com-
pared with 29% of those in the comparison area. This find-
ing may help explain why case-fatality rates were lower in 
the MCH-FP area than in the comparison area. However, 
the proportions of abortions performed at 12 weeks or 
*These later cases were disproportionately likely to be done by D&C; for 
example, 11% of “MR” cases that were terminated at 12 weeks or later 
were by D&C, compared with fewer than 2% of those terminated earlier 
in pregnancy.
TABLE 4. Percentage distribution of terminated pregnancies, by duration at time of termination, and mean duration—all  
according to area, time period and type of termination

















<6 wks.  7.9  5.1  9.4  6.1  6.0  4.3
6–7 wks. 22.9 11.8 33.9 22.7 16.7 16.9
8–9 wks. 25.1 18.0 25.2 23.8 31.1 29.5
10–11 wks. 16.3 19.5 14.4 12.7 17.0 17.5
≥12 wks. 27.8 45.6 17.1 34.8 29.2 32.0
Total 100.0 100.0 100.0 100.0 100.0 100.0
Mean duration (in wks.) 7.8 8.7 7.0 7.4 8.3 9.0
†Data for 1989–1999 are unavailable for the comparison area because information on the date of women’s last menstrual period was not collected until 
2001. ‡Data not available for 2001. §Includes pregnancy terminations performed by dilation and curettage, which accounted for 2% of terminations in this 
category. ††Different from distribution for menstrual regulation in 1989–1999 at p<.01. ‡‡Different from distribution for menstrual regulation in 1989–1999 
at p<.001. §§Different from distribution for abortion in 1989–1999 at p<.01. †‡Different from distribution for menstrual regulation in MCH-FP area in 2000–
2008 at p<.01. Note: Percentages may not total 100.0 because of rounding.




Use of drug (inserted, ingested   
or injected) 28.2 67.9
Internal manipulation of the genitalia 63.6 15.7
Manipulation of the abdomen   3.0   8.0
Other/unknown   5.2   8.4
Total 100.0 100.0
†Data not available for 2001. Note: The method distributions differ at p<.001. 
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tributable to the characteristics of women who seek such 
abortions.
In addition to the remarkable declines in the fatality 
rates for each type of termination, we found that MR ac-
counted for an increasing proportion of terminations— 
79% in 2000–2008 versus 55% in 1989–1999. Our 
simulation showed that the vast majority (85%) of the de-
crease in mortality associated with pregnancy termination 
was due to declines in method-specific case-fatality rates, 
rather than to the increased share of MR. Our analyses 
provide some suggestive evidence about the reasons for 
the declines in method-specific case-fatality rates: MR and 
abortion are now performed earlier in pregnancy than in 
the 1990s, and abortions are now done using less harm-
ful methods than in the past (fewer are done by internal 
manipulation of the genitalia, and more by use of drugs).
The various findings just mentioned—the reductions 
in case-fatality rates, the increasing share of terminations 
done by MR, the growing use of safer methods of abortion 
and the earlier gestational age at time of termination—pro-
vide some clues to why maternal mortality continues to 
decline in Bangladesh in spite of the increase in the preg-
nancy termination rate. However, the case-fatality rate asso-
ciated with MR in the comparison area in 2000–2008 was 
not as low as might be expected given that, if performed 
correctly, MR and D&C should have lower case-fatality 
rates than live births have. The reasons for this should be 
investigated. An investigation of MR in the MCH-FP area, 
where there were no deaths associated with the procedure 
in the more recent period, might yield some useful lessons 
for the comparison area. Furthermore, despite consider-
able declines, we still find unacceptably high mortality 
among women who obtain abortions. Systematic evalu-
ation should be done to find ways of reducing this risk. 
More information is also needed on why and under what 
conditions women seek abortion as an alternative to MR— 
a topic addressed by the next article in this issue.
lower in the MCH-FP area than in the comparison area dur-
ing both periods considered here, supporting our hypoth-
esis that women in the former area are less likely than those 
in the comparison area to terminate their pregnancies.
We found no differences between the two areas in case-
fatality rates for live births, despite the superior maternal 
health services in the MCH-FP area. Previous research4 
also found that the level of maternal mortality associated 
with live births was similar in the two areas of Matlab and 
attributed the lack of difference to the fact that the homes 
in both areas were, on average, equally accessible to the 
Chandpur District Hospital, which provides comprehen-
sive emergency obstetric care.15,25
The case-fatality rate for MRs in Matlab as a whole in 
1989–1999 was high—511 maternal deaths per 100,000. 
This is more than four times the rate associated with live 
birth, and more than twice the 220 per 100,000 mortal-
ity rate for unsafe terminations observed worldwide in 
2008.27 We conjectured that the risk associated with MR 
would be similar to, or even lower than, that for live birth, 
since MR is supposed to be a relatively safe method; ap-
parently, the method was not performed in a safe way in 
Matlab during the 1990s. It is encouraging that by 2000–
2008, the case-fatality rate had declined remarkably, to a 
level quite close to that of live birth—a solid indication of 
improvement in safety, and a tremendous achievement in 
reproductive health care in Bangladesh.
We also found, as hypothesized, that the mortality risk 
associated with abortion was higher than that associated 
with MR. In 1989–1999, the case-fatality rate for abortion 
was 1,480 maternal deaths per 100,000 abortions, more 
than six times that from unsafe abortions worldwide27 and 
12 times that for live birth in Matlab. The mortality risk for 
abortion declined dramatically, but in 2000–2008 it was 
still nearly five times that for live birth. This association 
was no longer apparent in the adjusted analysis, however, 
suggesting that the elevated mortality risk was largely at-

















Live birth 125 123 127 108 113 104 14 8 18
(78/62,528) (41/33,317) (37/29,211) (46/42,413) (24/21,281) (22/21,132)
All pregnancy 953 909 1,055 186‡ 230§ 105†† 81 75 90
terminations (24/2,518) (16/1,760) (8/758) (5/2,693) (4/1,738) (1/955)
Menstrual 511 638 233 94§§ 147 0 82 77 100
regulations‡‡ (7/1,369) (6/940) (1/429) (2/2,120) (2/1,362) (0/758)
Abortion 1,480†‡ 1,220 2,128†§ 524‡§ 532 508 65 56 76
(17/1,149) (10/820) (7/329) (3/573) (2/376) (1/197)
†Data not available for 2001. ‡Different from value for all pregnancy terminations in 1989–1999 at p<.05. §Different from value for all pregnancy terminations 
in comparison area in 1989–1999 at p<.05. ††Different from value for all pregnancy terminations in MCH-FP area in 1989–1999 at p<.05. ‡‡Includes pregnan-
cy terminations performed by dilation and curettage, which accounted for 2% of terminations in this category. §§Different from value for menstrual regula-
tions in comparison area in 1989–1999 at p<.05. †‡Different from value for menstrual regulations in comparison area in 1989–1999 at p<.05. †§Different from 
value for menstrual regulations in MCH-FP area in 1989–1999 at p<.05. ‡§Different from value for menstrual regulations in both areas in 2000–2008 at p<.05. 
Note: Case-fatality rates are per 100,000 cases.
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RESUMEN
Contexto: En Bangladesh, tanto la regulación menstrual 
(RM), método que se considera relativamente seguro, como 
el aborto, que supuestamente es un método menos seguro, se 
usan para la terminación del embarazo (confirmado o presun-
tivo). Sin embargo, se sabe poco sobre los cambios en el uso de 
estos métodos a través del tiempo o de la comparación de sus 
respectivos riesgos de mortalidad.
Métodos: Se usaron datos del Sistema de Vigilancia Demo-
gráfica de Matlab (Bangladesh) acerca de 110,152 resultados 
de embarazos ocurridos entre 1989 y 2008 para analizar los 
cambios en los riesgos de mortalidad asociados con la RM (así 
como con un número pequeño de procedimientos de dilatación 
y legrado), el aborto y el embarazo llevado a término. Se usa-
ron análisis de tabulación y regresión logística para comparar 
los resultados en dos zonas de Matlab—la zona de compara-
ción, la cual recibe servicios estándar de salud y planificación 
familiar del gobierno; y la zona de Salud Materna e Infantil-
Planificación Familiar (SMI-PF), la cual recibe mejores servi-
cios de salud y planificación familiar. 
Resultados: En todo Matlab, la proporción de embarazos 
que terminaron en RM aumentó de 1.9% en 1989–1999 a 
4.2% en 2000–2008, mientras que la proporción de los que 
terminaron en aborto disminuyó de 1.6% a 1.1%. Las proba-
bilidades de mortalidad relacionadas con la RM fueron 4.1 
veces mayores que las relativas a los  embarazos llevados a 
término en el período 1989-1999, pero dejaron de ser elevadas 
en 2000-2008. Por su parte, las probabilidades de mortalidad 
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cation familiale (SME-PF), bénéficiaire de meilleurs services.
Résultats: Sur l’ensemble de Matlab, la proportion des gros-
sesses interrompues par RM passe de 1,9% en 1989–1999 
à 4,2% en 2000–2008, tandis que celle des grossesses inter-
rompues par avortement diminue, de 1,6% à 1,1%. Le risque 
de mortalité associé à la RM représente 4,1 fois celui de la 
naissance vivante en 1989–1999, mais il n’est plus élevé en 
2000–2008. Celui de l’avortement représente, respectivement, 
12,0 et 4,9 fois celui de la naissance vivante en 1989–1999 et 
en 2000–2008. La réduction du risque de mortalité est supé-
rieure dans la zone SME-PF (90% par rapport à 75% dans la 
zone de comparaison).
Conclusion: La RM n’expose plus les femmes à un risque 
de mortalité élevé par rapport à celui de la naissance vivante; 
l’avortement, si.
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relacionadas al aborto fueron 12.0 y 4.9 veces mayores que las 
relativas a los embarazos llevados a término en 1989–1999 
y 2000–2008, respectivamente. La reducción en el riesgo de 
mortalidad fue mayor en la zona SMI-PF que en la zona de 
comparación (90% vs. 75%).
Conclusión: La RM ha dejado de exponer a las mujeres a un 
riesgo de mortalidad elevado en relación con los embarazos 
llevados a término; pero el aborto todavía lo hace.
RÉSUMÉ
Contexte: La régulation menstruelle (RM), considérée 
comme une méthode relativement sûre, et l’avortement, 
méthode vraisemblablement moins dénuée de risque, se pra-
tiquent tous deux au Bangladesh pour interrompre la grossesse 
(connue ou soupçonnée). L’évolution dans le temps du recours 
à ces méthodes et les risques de mortalité comparés ne sont 
cependant guère documentés.
Méthodes: Les données du Système de surveillance démogra-
phique de Matlab (Bangladesh) concernant 110 152 issues de 
grossesse entre 1989 et 2008, ont servi à évaluer l’évolution 
des risques de mortalité associés à la RM (ainsi qu’à un petit 
nombre de procédures de dilatation et curetage), à l’avorte-
ment et à la naissance vivante. Les issues ont été comparées 
par disposition en tableaux et analyses de régression logistique 
dans deux zones de Matlab: la zone de comparaison, qui béné-
ficie de services de santé et de planification familiale publics 
standard, et la zone Santé maternelle et de l’enfant–Planifi-
